Subsequent both in vitro and in vivo experiments distinctly demonstrate that cinchonine could induce apoptosis and reduce proliferation of cancer cells; and that the mode of action is blocking the AKT and TAK1 activations though interfering the formation of the TRAF6-Ubc13 complex. This evidence concerns the gene UBE2N and cancer.